Inovio Amends Chinese Deal for Immunotherapy, Shares Up – Nasdaq
FiercePharma |
Inovio Amends Chinese Deal for Immunotherapy, Shares Up
Nasdaq Shares of Inovio Pharmaceuticals, Inc. INO ) have gained about 13.32%, after the company announced that it has entered into an amended agreement with Chinese partner – ApolloBio Corporation. Per the amended agreement, ApolloBio will have the exclusive … Inovio grabs $23M through HPV immunotherapy licensing deal with China's ApolloBio Inovio Enters License and Collaboration Agreement with ApolloBio To Develop and Commercialize VGX-3100 in … Could Inovio Pharmaceuticals, Inc. (INO) Rise Even More? The Stock Had Another Big Increase Today |
